Assay Technology

• A unique, non-artificial, non 3D equivalent human in vitro assay technology allows the study of immune responses to new compounds, chemicals, cosmetics and novel therapeutics without the need for extensive animal testing.

• Incubation with human skin, allows skin damage to be assessed by histopathology. The skin is graded for histological damage using criteria similar to that used and observed in the clinical setting. Results correlate with systemic disease and have been shown to predict outcome.

• The reproducibility 94.2% and 91.8% based on negative and positive controls respectively.

Read out shows degree of damage by novel compounds graded in severity from I (A) to
III (C)

Patents -

UK Patent pending: in vitro detection of skin sensitisation and allergy

GB1020004.6;  GB1115537.1